Investigación / Grupos de investigación

Área 4 Microbiología Clínica, Enfermedades Infecciosas y SIDA

Grupo  1

Enfermedades Infecciosas

Publicaciones (1244)

  • Galar, A; Martin-Rabadan, P; Marin, M; Cercenado, E; Sanchez-Carrillo, C; Valerio, M; Bouza, E; Munoz, P.

    Revisiting nocardiosis at a tertiary care institution: Any change in recent years?

    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021; 102: 446-454 Nº de citas: 11 [doi:10.1016/j.ijid.2020.10.087]

  • Arendrup, MC; Kahlmeter, G; Guinea, J; Meletiadis, J; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European.

    How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton

    CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(1): 55-60 Nº de citas: 75 [doi:10.1016/j.cmi.2020.08.042]

  • Serrano-Lobo, J; Gomez, A; Sanchez-Yebra, W; Fajardo, M; Lorenzo, B; Sanchez-Reus, F; Vidal, I; Fernandez-Torres, M; Sanchez-Romero, I; de Alegria-Puig, CR; del Pozo, JL; Muñoz P; Escribano, P; Guinea, J.

    Azole and Amphotericin B MIC Values against Aspergillus fumigatus: High Agreement between Spectrophotometric and Visual Readings Using the EUCAST EDef 9.3.2 Procedure

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2021; 65(1): Nº de citas: 9 [doi:10.1128/AAC.01693-20]

  • Butragueno-Laiseca, L; Troconiz, IF; Grau, S; Campillo, N; Garcia, X; Padilla, B; Fernandez, SN; Santiago, MJ.

    Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury

    Antibiotics-Basel. 2020; 9(12): Nº de citas: 11 [doi:10.3390/antibiotics9120887]

  • Guinea, J.

    Updated EUCAST Clinical Breakpoints against Aspergillus, Implications for the Clinical Microbiology Laboratory

    Journal of Fungi. 2020; 6(4): Nº de citas: 25 [doi:10.3390/jof6040343]

  • Zvezdanova, ME; Arroyo, MJ; Mendez, G; Guinea, J; Mancera, L; Munoz, P; Rodriguez-Sanchez, B; Escribano, P.

    Implementation of MALDI-TOF Mass Spectrometry and Peak Analysis: Application to the Discrimination of Cryptococcus neoformans Species Complex and Their Interspecies Hybrids

    Journal of Fungi. 2020; 6(4): Nº de citas: 10 [doi:10.3390/jof6040330]

  • Candel, FJ; Barreiro, P; San Roman, J; Abanades, JC; Barba, R; Barberan, J; Bibiano, C; Canora, J; Canton, R; Calvo, C; Carretero, M; Cava, F; Delgado, R; Garcia-Rodriguez, J; del Castillo, JG; de Villaumbrosia, CG; Hernandez, M; Losa, JE; Martinez-Peromingo, FJ; Molero, JM; Munoz, P; Onecha, E; Onoda, M; Rodriguez, J; Sanchez-Celaya, M; Serra, JA; Zapatero, A.

    Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2020; 33(6): 466-484 Nº de citas: 57 [doi:10.37201/req/120.2020]

  • Vinuela, MC; De Leon-Luis, JA; Alonso, R; Catalan, P; Lizarraga, S; Munoz, P; Bouza, E; Gregorio Maranon Obstet Gynecology.

    SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2020; 33(6): 415-421 Nº de citas: 2 [doi:10.37201/req/088.2020]

  • Alonso, B; Fernandez-Barat, L; Di Domenico, EG; Marin, M; Cercenado, E; Merino, I; de Pablos, M; Munoz, P; Guembe, M.

    Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia

    BMC INFECTIOUS DISEASES. 2020; 20(1): Nº de citas: 63 [doi:10.1186/s12879-020-05534-1]

  • Rubia, M; Cordero, A; Perez-Granda, MJ; Cercenado, E; Pascual, C; Munoz, P; Guembe, M.

    In Vitro Study To Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020; 64(12): Nº de citas: 6 [doi:10.1128/AAC.01495-20]

  • Hoste, ACR; Venteo, A; Fresco-Taboada, A; Tapia, I; Monedero, A; Lopez, L; Jebbink, MF; Perez-Ramirez, E; Jimenez-Clavero, MA; Almonacid, M; Munoz, P; Guinea, J; Vela, C; van der Hoek, L; Rueda, P; Sastre, P.

    Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test

    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2020; 98(4): Nº de citas: 17 [doi:10.1016/j.diagmicrobio.2020.115167]

  • Bouza, E; Burillo, A; de Egea, V; Hortal, J; Barrio, JM; Vicente, T; Muñoz P; Perez-Granda, MJ.

    Colonization of the nasal airways by Staphylococcus aureus on admission to a major heart surgery operating room: A real-world experience

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2020; 38(10): 466-470 Nº de citas: 6 [doi:10.1016/j.eimc.2019.07.013]

  • Aydillo, T; Escalera, A; Strohmeier, S; Aslam, S; Sanchez-Cespedes, J; Ayllon, J; Roca-Oporto, C; Perez-Romero, P; Montejo, M; Gavalda, J; Munoz, P; Lopez-Medrano, F; Carratala, J; Krammer, F; Garcia-Sastre, A; Cordero, E.

    Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    CELL REPORTS MEDICINE. 2020; 1(8): 100130-100130 Nº de citas: 24 [doi:10.1016/j.xcrm.2020.100130]

  • Escribano, P; Alvarez-Uria, A; Alonso, R; Catalan, P; Alcal, L; Munoz, P; Guinea, J.

    Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19

    Scientific Reports. 2020; 10(1): Nº de citas: 24 [doi:10.1038/s41598-020-76914-5]

  • Cordero, E; Goycochea-Valdivia, W; Mendez-Echevarria, A; Allende, LM; Alsina, L; Garcia-Morato, MB; Gil-Herrera, J; Gudiol, C; Len-Abad, O; Lopez-Medrano, F; Moreno-Perez, D; Munoz, P; Olbrich, P; Sanchez-Ramon, S; Soler-Palacin, P; Cros, CA; Arostegui, JI; Serra, IB; Carbone, J; Fortun, J; Gonzalez-Granado, LI; Lopez-Granados, E; Lucena, JM; Parody, R; Ramakers, J; Regueiro, JR; Riviere, JG; Roca-Oporto, C; Pena, RR; Santos-Perez, JL; Rodriguez-Gallego, C; Neth, O.

    Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Journal of Allergy and Clinical Immunology-In Practice. 2020; 8(10): 3342-3347 Nº de citas: 9 [doi:10.1016/j.jaip.2020.05.008]

  • Cordero, E; Goycochea-Valdivia, W; Mendez-Echevarria, A; Allende, LM; Alsina, L; Garcia-Morato, MB; Gil-Herrera, J; Gudiol, C; Len-Abad, O; Lopez-Medrano, F; Moreno-Perez, D; Munoz, P; Olbrich, P; Sanchez-Ramon, S; Soler-Palacin, P; Cros, CA; Arostegui, JI; Serra, IB; Carbone, J; Fortun, J; Gonzalez-Granado, LI; Lopez-Granados, E; Lucena, JM; Parody, R; Ramakers, J; Regueiro, JR; Riviere, JG; Roca-Oporto, C; Pena, RR; Santos-Perez, JL; Rodriguez-Gallego, C; Neth, O.

    Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2020; 38(9): 438-443 Nº de citas: 1 [doi:10.1016/j.eimc.2020.07.001]

  • Marcos-Zambrano, LJ; Gomez, A; Sanchez-Carrillo, C; Bouza, E; Munoz, P; Escribano, P; Guinea, J.

    Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect

    CLINICAL MICROBIOLOGY AND INFECTION. 2020; 26(11): 1589-1592 Nº de citas: 12 [doi:10.1016/j.cmi.2020.07.023]

  • Arendrup, MC; Friberg, N; Mares, M; Kahlmeter, G; Meletiadis, J; Guinea, J; Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European.

    How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST)

    CLINICAL MICROBIOLOGY AND INFECTION. 2020; 26(11): 1464-1472 Nº de citas: 136 [doi:10.1016/j.cmi.2020.06.007]